एशिया-प्रशांत मलेरिया उन्मूलन: प्रगति, चुनौतियाँ, और भारत का 2027 लक्ष्य

The Asia Pacific Leaders Malaria Alliance (APLMA) is a group uniting 22 governments in the Asia-Pacific region. Its goal is to eliminate malaria in the region by 2030.

The World Malaria Report 2025 indicates mixed progress in the Asia-Pacific region. While Southeast Asia saw a reduction in estimated malaria cases, rising resistance to artemisinin-based treatments and declining funding for malaria programs remain concerns. Ten malaria-endemic countries drove a significant reduction.

India has set an ambitious target of achieving zero indigenous malaria cases by 2027, ahead of the global goal.

Artemisinin resistance threatens the effectiveness of artemisinin-based combination therapies (ACTs), which are the first-line treatment for malaria. If these treatments fail, it becomes much harder to control and eliminate the disease.

Recent developments include a renewed focus on innovative approaches to malaria control, including the use of genetically modified mosquitoes and malaria vaccines. The RTS,S/AS01 vaccine (Mosquirix) and R21/Matrix-M vaccine have shown promising results.

Pros: It can galvanize resources and focus efforts. Cons: It may lead to rushed implementation and potential setbacks if not well-planned. Success depends on factors like funding, surveillance, and addressing artemisinin resistance.

Declining funding can hinder malaria control efforts in the Asia-Pacific region by limiting access to essential tools like insecticide-treated bed nets, diagnostic testing, and effective treatments. It can also weaken surveillance systems and research efforts.

The reductions in these countries demonstrate that progress is possible with targeted interventions and sustained efforts. They serve as examples for other countries in the region.

According to the topic data, only 42% of global malaria financing needs were met in 2024.

Successful malaria elimination would reduce healthcare costs, improve worker productivity, and enhance overall public health, especially for vulnerable populations like children and pregnant women.